These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10418925)

  • 1. Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice.
    Katayama S; Oda K; Ohgitani T; Hirahara T; Shimizu Y
    Vaccine; 1999 Jun; 17(20-21):2733-9. PubMed ID: 10418925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of antigenic forms and adjuvants on protection against a lethal infection of Aujeszky's disease virus.
    Katayama S; Oda K; Ohgitani T
    Vaccine; 2000 Aug; 19(1):54-8. PubMed ID: 10924786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.
    Ghochikyan A; Mkrtichyan M; Petrushina I; Movsesyan N; Karapetyan A; Cribbs DH; Agadjanyan MG
    Vaccine; 2006 Mar; 24(13):2275-82. PubMed ID: 16368167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
    Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
    Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
    Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
    Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection.
    Hancock GE; Speelman DJ; Frenchick PJ; Mineo-Kuhn MM; Baggs RB; Hahn DJ
    Vaccine; 1995 Mar; 13(4):391-400. PubMed ID: 7793137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Survey on the Adjuvant Role of Naloxone Alone or Combined with Alum in Vaccination Against Fasciolosis in BALB/c Mice.
    Azizi H; Mirzaeei H; Bagheri A; Bazi A; Khamesipour A; Yaghoobi H; Mirzapour A; Khatami M; Elikaee S
    Acta Parasitol; 2019 Jun; 64(2):236-245. PubMed ID: 30788648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children.
    Nakayama T; Kumagai T; Ishii KJ; Ihara T
    Vaccine; 2012 Dec; 30(52):7662-6. PubMed ID: 23102974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
    Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
    Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21.
    Beck Z; Matyas GR; Jalah R; Rao M; Polonis VR; Alving CR
    Vaccine; 2015 Oct; 33(42):5578-5587. PubMed ID: 26372857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo.
    Germann T; Bongartz M; Dlugonska H; Hess H; Schmitt E; Kolbe L; Kölsch E; Podlaski FJ; Gately MK; Rüde E
    Eur J Immunol; 1995 Mar; 25(3):823-9. PubMed ID: 7705414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice against Aujeszky's disease virus infection by intranasal vaccination with inactivated virus.
    Takada A; Shimizu Y; Kida H
    J Vet Med Sci; 1994 Aug; 56(4):633-7. PubMed ID: 7999882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamins as influenza vaccine adjuvant components.
    Quintilio W; de Freitas FA; Rodriguez D; Kubrusly FS; Yourtov D; Miyaki C; de Cerqueira Leite LC; Raw I
    Arch Virol; 2016 Oct; 161(10):2787-95. PubMed ID: 27449155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
    Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
    Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.
    Magnusson SE; Reimer JM; Karlsson KH; Lilja L; Bengtsson KL; Stertman L
    Vaccine; 2013 Mar; 31(13):1725-33. PubMed ID: 23384754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
    Xie Y; Sun HX; Li D
    Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.
    Ishii H; Kobayashi Y; Kuroki M; Kodama Y
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1411-4. PubMed ID: 2838579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
    Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
    Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in mice.
    Zaharatos GJ; Yu J; Pace C; Song Y; Vasan S; Ho DD; Huang Y
    Vaccine; 2011 Dec; 30(1):42-50. PubMed ID: 22064264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.